Page 5 - Joshua Rosenblat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Braxia Scientific to Commence Landmark Clinical Trial to Conduct Canada s First Multiple-Dose Psilocybin Clinical Trial for Treatment Resistant Depression

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics.

Roger mcintyreRogers mcintyreJoshua rosenblatBraxia scientific corpExcellence incBraxia health canadian rapid treatment centersBraxia instituteCanadian rapid treatment centre of excellence incCanadian rapid treatment centerBraxia healthCanadian rapid treatment centersBraxia scientificCanadian rapid treatment centreControlled drugsSubstances actRestated listing statement

Braxia Scientific Corp announces Canada s first multiple-dose psilocybin clinical trial for treatment-resistant depression

Braxia Scientific Corp announces Canada s first multiple-dose psilocybin clinical trial for treatment-resistant depression
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Roger mcintyreJoshua rosenblatCanadian rapid treatment centre of excellenceBraxia scientific corpUs district court central of californiaCanadian rapid treatment centreCourt central districtExchange act

Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results

Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRoger mcintyreRogers mcintyreDavid greenbergOlga cwiekJoshua rosenblatBraxia healthUniversity health networkBraxia scientific corpInternational expert opinionConcussion programUniversity of torontoDevelopment foothold in ketamine assisted therapyExcellence incAltmed capital corpHomewood health centre

Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression

Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Roger mcintyreRogers mcintyreJosh rosenblatJoshua rosenblatBraxia scientific corpNational institute of healthToronto university health networkResearch clinicExcellence incBraxia health canadian rapid treatment centerCanadian institute of health researchHealth canadaCanadian rapid treatment centerCanadian instituteHealth researchUniversity health network

/R E P E A T -- Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/

/R E P E A T -- Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.